Deflazacort
Orphan DrugFDA Approved
Contents
Description
Deflazacort is a corticosteroid used to treat Duchenne muscular dystrophy. It works by reducing inflammation and suppressing the immune system.
Indications & Therapeutic Use
autosomal recessive limb-girdle muscular dystrophy type 2U
Linked Diseases:
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Buy / Source Deflazacort — GNH India
57 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Calcort
EU
Decor
EU
Defal
EU
Defcort 1mg
1 mgtabletIndia
Defcort 30
30mg
Defcort 30ml
30ml
Defcort 6mg
6 mgtabletIndia
Deflan
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Deflazacort
| Generic Name | Deflazacort |
| Brands | 1 brand available |
| Active Ingredient | Deflazacort |
| Drug Class | autosomal recessive limb-girdle muscular dystrophy type 2U |
| Manufacturer | Marathon Pharmaceuticals |
| Dosage Forms | Oral tablet, Oral suspension |
| Medical Code | H02AB04 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00850449 |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes